Celebrex official prescribing information ..

CELEBREX is a nonsteroidal anti-inflammatory drug that exhibits anti-inflammatory, analgesic, and antipyretic activities in animal models. The mechanism of action of CELEBREX is believed to be due to inhibition of prostaglandin synthesis, primarily via inhibition of cyclooxygenase-2 (COX-2), and at therapeutic concentrations in humans, CELEBREX does not inhibit the cyclooxygenase-1 (COX-1) isoenzyme. In animal colon tumor models, celecoxib reduced the incidence and multiplicity of tumors.

Click here to processing! skip to main | skip to sidebar. synthesis of celebrex

Celecoxib produced pre-implantation and post-implantation losses and reduced embryo/fetal survival in rats at oral dosages ≥50 mg/kg/day (approximately 6-fold human exposure based on the AUC at 200 mg BID). These changes are expected with inhibition of prostaglandin synthesis and are not the result of permanent alteration of female reproductive function, nor are they expected at clinical exposures. No studies have been conducted to evaluate the effect of celecoxib on the closure of the ductus arteriosus in humans. Therefore, use of CELEBREX during the third trimester of pregnancy should be avoided.

Celebrex® (celecoxib) - Pfizer for Professionals

The drug is currently marketed as Celebrex in the United States of America

Dementia is a progressive decline in brain function from disease or damage to the body well beyond what is expected from aging. This affliction affects memory, attention, language, and problem solving, with higher mental function suffering first in the process. In the later stages of dementia people may become disoriented in place and in person.